Literature DB >> 19326509

Sublingual immunotherapy in children: complete and updated review supporting evidence of effect.

Desiree Larenas-Linnemann1.   

Abstract

PURPOSE OF REVIEW: The interest in sublingual immunotherapy (SLIT) is still growing worldwide and especially for the pediatric age group, this modality is appealing. Lately, some negative systematic review articles have been published on SLIT in children. However, high quality articles published from 2007 onward had not been included. RECENT
FINDINGS: Explanations are sought for the negative outcomes in these reviews and shortcomings are discussed. New pediatric studies - not included in the previous reviews -designed taking into account the golden rules for SLIT (high daily dose, starting at least 4 months before pollen season) do show statistically significant improvement in symptom and medication scores for rhinitis and asthma in pollen allergy. New house dust mite studies still show inconsistent data.
SUMMARY: Evidence of effect is confirmed for SLIT in children with allergic rhinitis or asthma caused by pollen exposure. For house dust mite asthma, evidence is still nonconcordant. New techniques to improve SLIT efficacy are under investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326509     DOI: 10.1097/aci.0b013e328329a2a9

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  9 in total

Review 1.  Will sublingual immunotherapy offer benefit for asthma?

Authors:  Carlos E Baena-Cagnani; Désirée Larenas-Linnemann; Alvaro Teijeiro; Giorgio Walter Canonica; Giovanni Passalacqua
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

Review 2.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

3.  Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet.

Authors:  Cristoforo Incorvaia; Gian Galeazzo Riario-Sforza; Stefano Incorvaia; Franco Frati
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

4.  Quality of life improvement with sublingual immunotherapy: a prospective study of efficacy.

Authors:  Mary S Morris; Amanda Lowery; Demetrios S Theodoropoulos; R Daniel Duquette; David L Morris
Journal:  J Allergy (Cairo)       Date:  2012-01-30

5.  Sublingual immunotherapy in asthma does not influence lymphocyte sensitivity to Fas stimulation.

Authors:  Olga Ciepiela; A Zawadzka-Krajewska; I Kotula; M Wasik; U Demkow
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

Review 6.  Optimal management of allergic rhinitis.

Authors:  Glenis K Scadding
Journal:  Arch Dis Child       Date:  2015-04-02       Impact factor: 3.791

Review 7.  Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.

Authors:  Giovanni Battista Pajno; Roberto Bernardini; Diego Peroni; Stefania Arasi; Alberto Martelli; Massimo Landi; Giovanni Passalacqua; Antonella Muraro; Stefania La Grutta; Alessandro Fiocchi; Luciana Indinnimeo; Carlo Caffarelli; Elisabetta Calamelli; Pasquale Comberiati; Marzia Duse
Journal:  Ital J Pediatr       Date:  2017-01-23       Impact factor: 2.638

8.  Sublingual immunotherapy for pediatric patients with mite allergies.

Authors:  Teruyuki Kajiume
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

9.  Sublingual immunotherapy in children: facts and needs.

Authors:  Gian Luigi Marseglia; Cristoforo Incorvaia; Mario La Rosa; Franco Frati; Francesco Marcucci
Journal:  Ital J Pediatr       Date:  2009-10-23       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.